| EXECUTIVE PROFILE |

Rodrigo
Garelik

SENIOR PHARMA LEADER

I lead pharma businesses and advisory platforms. AI is the multiplier, not the message.

Since 1996, I have worked across the pharmaceutical industry: medical promotion, pharmaceutical marketing, P&L, commercial leadership and country-level responsibility in Paraguay and other markets. Today, I build and operate my own businesses.

By scheduling, you agree to be contacted by Rodrigo Garelik / RGrlk Group via email or corporate WhatsApp (+595 981 467 259), subject to the rgrlk.com privacy policy.

Rodrigo Garelik, senior pharmaceutical executive and founder of RGrlk Group
| ASUNCIÓN · PARAGUAY |
Pharma 360°End-to-end understanding and execution across the pharma business: OTX, OTC, market access, Health Care & Beauty and mass-market channels.
Leadership & ScaleProven ranking growth across brands, franchises, business lines and laboratories, supported by documented market-audit evidence.
Owned BusinessesFounder and operator of RGrlk Group: advisory, training and AI products with real revenue and direct operating control.
AI-Enhanced Execution720 certified hours in Prompt Engineering (CENTEIA PRO) plus a university diploma in Generative AI & Automation.

A CV explains the past. This is what I can execute tomorrow.

Five capabilities proven in real markets

P&L & Executive Leadership

Full ownership of the numbers, the team and the market, with no gap between strategy and results.

Launches & Go-to-Market

Pharmaceutical marketing, targeting, call frequency and SFE. Disciplined field execution.

LATAM Market Access

Paraguay and the region understood from the inside: institutional, hospital, private and public channels.

Applied AI for Commercial Operations

Automation, AI agents and dashboards designed for everyday team use.

Owned Businesses

RGrlk Group operates with real revenue, direct control and real clients. Cash flow first, scale second.

Let’s discuss your operation

From the medical office to the executive decision table. Each stage explains how I execute today.

01

2024 — Present

RGrlk Group · Lab.IA

Founder & CEO. Four business units, applied-AI products and a revenue-generating operating asset.

02

2025

LQF · Nutricia Danone

New Projects Manager. Launch, positioning and cross-functional coordination for Paraguay.

03

2023 — 2024

Abbott Paraguay

Medical Promotion Manager. Five therapeutic lines and 23 medical representatives: redesigned structure, targeting and call frequency.

04

2022

Grupo Scavone · REXIM / INCARE

Corporate Manager. Commercial and marketing leadership for two acquired companies: launch, consolidation and operational integration.

05

2019 — 2022

Eurofarma Paraguay

Commercial Manager with Country Manager responsibilities. Full commercial restructuring and significant IQVIA ranking improvement.

06

1996 — 2019

Roemmers · Megalabs · Grünenthal

From medical representative to manager of 45 brands: ABRILAR +65%, PIASCLEDINE +41%, CHELTIN +21%.

View full career

Let’s talk if you are facing any of these scenarios:

  • ✓You need a CEO, Country Manager or Commercial Director who has already turned around a difficult market.
  • ✓You are entering Paraguay or LATAM and need real market intelligence, not a purchased report.
  • ✓Your portfolio, pricing and sales force need structure, accountability and P&L discipline.
  • ✓You need distributor screening and commercial feasibility assessment before committing the first dollar.
  • ✓You want AI in the business with executive judgment: focused on cash flow, margin and decision speed.
Message me on WhatsApp
Rodrigo Garelik — executive black-and-white portrait
Rodrigo Garelik, founder of RGrlk Group

Senior executive. Business builder. No unnecessary rhetoric.

I entered the pharmaceutical industry in 1996 as a medical representative and progressed one level at a time: specialist representative, supervisor, product leadership, therapeutic-area management, Marketing Manager, Medical Promotion Manager, Corporate Manager, Commercial Director and country-level responsibility. I understand execution at every level because I have done the work myself.

Today I combine that track record with applied Artificial Intelligence and venture building through RGrlk Group and its business units: Lab.IA, Pharma.IA, Lab.IA Institut and E1637. I use AI as a multiplier of executive judgment, not as a narrative.

I add value where transformation is required: C-Level roles with real ownership and selected advisory mandates across Paraguay and LATAM. One conversation. One concrete problem. One clear next step.

ceo.rgrlk@rgrlk.com · +595 981 467 259

Founder & CEO · RGrlk Group · Asunción, Paraguay